Source: GlobeNewswire

Press Release: NeuroStar : Neuronetics Reports Fourth Quarter and Full Year 2018 Financial and Operating Results

MALVERN, Pa., March 05, 2019 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders, today announced its financial and operating results for the fourth quarter and full year December 31, 2018.

Read full article »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Based on data from NeuroStar's latest SEC filings

Annual Revenue

Based on data from NeuroStar's latest SEC filings

Employees

Christopher Thatcher's photo - President & CEO of NeuroStar

President & CEO

Christopher Thatcher

CEO Approval Rating

80/100

NeuroStar focuses on developing and commercializing non-invasive therapies for the treatment of chronic psychiatric and ... Read more